Sana Biotechnology, Inc. (SANA) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $256.01M | +2.2% |
| 2024 | $250.52M | -9.8% |
| 2023 | $277.79M | -14.1% |
| 2022 | $323.40M | -19.3% |
| 2021 | $400.90M | +34.3% |
| 2020 | $298.58M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $256.01M | +2.2% |
| 2024 | $250.52M | -9.8% |
| 2023 | $277.79M | -14.1% |
| 2022 | $323.40M | -19.3% |
| 2021 | $400.90M | +34.3% |
| 2020 | $298.58M | — |